Pharmaceuticals - Barcelona, Catalunya, Spain
A company focused on developing novel drugs addressing major ophthalmic unmet medical needs, with especial focus on ocular surface diseases. The company was founded in July 2013 on the grounds of neurobiological research performed by the Group on Ocular Sensory Innervation led by Prof. Carlos Belmonte at the Instituto de Neurociencias de Alicante, and its operations are carried from Barcelona.
Outlook
Nginx
New Relic
Amazon AWS
Adobe Marketing Cloud
Mobile Friendly